Search

Displaying results 4231 - 4240 of 10000 in total
  1. Indication

    Community Acquired Pneumonia (CAP) caused by Escherichia Coli Infection

    go.drugbank.com/conditions/DBCOND0165526
    Drugs: Ceftobiprole medocaril
    Synonyms: Community Acquired Pneumonia (CAP) caused by Escherichia Coli Infection
  2. Indication

    Community Acquired Pneumonia (CAP) caused by Klebsiella Pneumoniae Infection

    go.drugbank.com/conditions/DBCOND0165527
    Drugs: Ceftobiprole medocaril
    Synonyms: Community Acquired Pneumonia (CAP) caused by Klebsiella Pneumoniae Infection
  3. Indication

    Community Acquired Pneumonia (CAP) caused by Streptococcus Pneumoniae Infections

    go.drugbank.com/conditions/DBCOND0165525
    Drugs: Ceftobiprole medocaril
    Synonyms: Community Acquired Pneumonia (CAP) caused by Streptococcus Pneumoniae Infections
  4. Drug

    Cosibelimab

    go.drugbank.com/drugs/DB15770
    ApprovedInvestigational

    On December 13, 2024, cosibelimab was approved by the FDA for the treatment of metastatic or locally advanced cutaneous squamous cell carcinoma [L52690] as the first approved anti-PD-L1 therapy in the … Cosibelimab is a human IgG1 lambda monoclonal antibody directed against programmed death ligand-1 (PD-L1).

    Synonyms: anti-Pd-l1 monoclonal antibody CK-301, IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL CK-301 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CK-301 .LAMBDA.-CHAIN, DIMERCategories: Amino Acids, Peptides, and Proteins
  5. Drug

    Cefmetazole

    go.drugbank.com/drugs/DB00274
    Approved

    It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted. … A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms.

  6. Drug

    Clonixin

    go.drugbank.com/drugs/DB09218
    Investigational

    Clonixin is a non-steroidal anti-inflammatory drug.

    Mixtures: CLONIXINATO / CICLOBENZAPRINA 125MG/5MGCategories: Amino Acids, Peptides, and Proteins
  7. Drug

    Dalfopristin

    go.drugbank.com/drugs/DB01764
    Approved

    Dalfopristin is a combination of two antibiotics (Dalfopristin and quinupristin) used to treat infections by staphylococci and by vancomycin-resistant Enterococcus faecium. … Dalfopristin inhibits the early phase of protein synthesis in the bacterial ribosome and quinupristin inhibits the late phase of protein synthesis.

    Categories: Amino Acids, Peptides, and Proteins
  8. Drug

    Rivabazumab pegol

    go.drugbank.com/drugs/DB17788
    Investigational

    Rivabazumab pegol is being investigated as a treatment of Pseudomonas aeruginosa lung infections in patients with cystic fibrosis.[A259457]

    Synonyms: KB001-A (AN ANTI-PCRV PEGYLATED MONOCLONAL ANTIBODY FRAGMENT TO THE TYPE III SECRETION SYSTEM OF PSEUDOMONAS AERUGINOSA)
  9. Drug

    N-methylnicotinamide

    go.drugbank.com/drugs/DB08840
    Investigational

    It is a metabolite of niacinamide/nicotinamide and niacin/nicotinic acid (vitamin B3), and as such N-methylnicotinamide is used to diagnose niacin deficiency by measuring N-methylnicotinamide in the urine … N-methylnicotinamide is an experimental drug with no approved indication or marketed formulation.

    Categories: Bile and Liver Therapy, Alimentary Tract and MetabolismSynonyms: N-Methyl nicotineamide, 3-(N-Methylcarbamoyl)pyridine
  10. Drug

    Tavaborole

    go.drugbank.com/drugs/DB09041
    Approved

    Tavaborole functions by inhibiting Leucyl-tRNA synthetase, or LeuRS, an essential fungal enzyme required for protein synthesis and for the catalysis of ATP-dependent ligation of L-leucine to tRNA(Leu). … Tavaborale is a novel, boron-based topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed due to *Trichophyton rubrum* or *Trichophyton mentagrophytes